SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                ----------------


                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934



         Date of Report (Date of earliest event reported): June 1, 2005



                             ProUroCare Medical Inc.

               (Exact Name of Registrant as Specified in Charter)



           Nevada                    333-103781                20-1212923
(State or Other Jurisdiction      (Commission File           (IRS Employer
     of Incorporation)                Number)            Identification Number)


       One Carlson Parkway, Suite 124
             Plymouth, Minnesota                                 55447
  (Address of Principal Executive Offices)                     (Zip Code)


       Registrant's telephone number, including area code: (952) 476-9093



          (Former Name or Former Address, if Changed Since Last Report)

<PAGE>

Item 1.01   Entry into Material Definitive Agreements

      On  June 1,  2005  the  Company's  compensation  committee  and  Board  of
Directors  approved the framework for the 2005  executive  management  incentive
compensation  plan.  Under this plan, the maximum  incentive  compensation to be
paid to members of the management  team will be 30% of each  executive's  salary
or, if so  specified,  the  percentage of salary  specified in each  executive's
employment agreement.

         The maximum incentive compensation for each named executive is:

                  Maurice R. Taylor         75% of salary

                  Michael P. Grossman       50% of salary

      Mr. Taylor's and Mr. Grossman's 2005 incentive  compensation will be based
on the achievement of certain product development  milestones during the year as
determined by the compensation committee.

The remaining executives qualify for a incentive compensation of up to of 30% of
their salaries,  based on the attainment of a combination of corporate goals and
personal objectives established for each individual.


<PAGE>

                                   SIGNATURES

      Pursuant to the  requirements  of the Securities and Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                        PROUROCARE MEDICAL INC.


Date:  June 6, 2005                     By:  /s/ Maurice R. Taylor
                                           -------------------------
                                            Maurice R. Taylor,
                                            Chairman and Chief Executive Officer
{"company-data": {"conformed-name": "ProUroCare Medical Inc.", "cik": "0001222244", "assigned-sic": "3841", "irs-number": "000000000", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-103781", "film-number": "05880773"}, "business-address": {"street1": "ONE CARLSON PARKWAY", "street2": "SUITE 124", "city": "PLYMOUTH", "state": "MN", "zip": "55447", "phone": "2127304305"}, "mail-address": {"street1": "ONE CARLSON PARKWAY", "street2": "SUITE 124", "city": "PLYMOUTH", "state": "MN", "zip": "55447"}, "former-company": [{"former-conformed-name": "ProUroCare", "date-changed": "20041004"}, {"former-conformed-name": "GLOBAL INTERNET COMMUNICATIONS INC", "date-changed": "20030310"}]}
SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                ----------------

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

         Date of Report (Date of earliest event reported): June 1, 2005

                             ProUroCare Medical Inc.

               (Exact Name of Registrant as Specified in Charter)

           Nevada                    333-103781                20-1212923
(State or Other Jurisdiction      (Commission File           (IRS Employer
     of Incorporation)                Number)            Identification Number)

       One Carlson Parkway, Suite 124
             Plymouth, Minnesota                                 55447
  (Address of Principal Executive Offices)                     (Zip Code)

       Registrant's telephone number, including area code: (952) 476-9093

          (Former Name or Former Address, if Changed Since Last Report)
Item 1.01   Entry into Material Definitive Agreements

      On  June 1,  2005  the  Company's  compensation  committee  and  Board  of
Directors  approved the framework for the 2005  executive  management  incentive
compensation  plan.  Under this plan, the maximum  incentive  compensation to be
paid to members of the management  team will be 30% of each  executive's  salary
or, if so  specified,  the  percentage of salary  specified in each  executive's
employment agreement.

         The maximum incentive compensation for each named executive is:

                  Maurice R. Taylor         75% of salary

                  Michael P. Grossman       50% of salary

      Mr. Taylor's and Mr. Grossman's 2005 incentive  compensation will be based
on the achievement of certain product development  milestones during the year as
determined by the compensation committee.

The remaining executives qualify for a incentive compensation of up to of 30% of
their salaries,  based on the attainment of a combination of corporate goals and
personal objectives established for each individual.
SIGNATURES

      Pursuant to the  requirements  of the Securities and Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                        PROUROCARE MEDICAL INC.

Date:  June 6, 2005                     By:  /s/ Maurice R. Taylor
                                           -------------------------
                                            Maurice R. Taylor,
                                            Chairman and Chief Executive Officer